Moneycontrol
Last Updated : May 17, 2018 09:36 AM IST | Source: Moneycontrol.com

Divis Laboratories gains 4% after USFDA inspection with no observations

This was a general cGMP inspection by the FDA and it has been concluded with no 483 observations.

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Divis Laboratories added 4 percent in the opening trade on Thursday as USFDA completed inspection with no 483 observations.

The company's unit-I at Choutuppal, Telangana had an inspection by USFDA from May 14-16.

This was a general cGMP inspection by the FDA and it has been concluded with no 483 observations.

The company's board meeting is scheduled to be held on May 26, 2018, to consider and approve standalone and consolidated audited financial results for the year ended March 31, 2018 and to recommend dividend, if any, on equity shares for the financial year 2017-18.

graph_divis

At 09:22 hrs Divis Laboratories was quoting at Rs 1,207.45, up Rs 41.30, or 3.54 percent on the BSE.

Posted by Rakesh Patil
First Published on May 17, 2018 09:34 am
Loading...
Sections
Follow us on
Available On